1 / 6

U.S. Emerging Lung Cancer Therapeutics Markets Novel Targeted Therapies Lower Side Effects

U.S. Emerging Lung Cancer Therapeutics Markets Novel Targeted Therapies Lower Side Effects.

lona
Download Presentation

U.S. Emerging Lung Cancer Therapeutics Markets Novel Targeted Therapies Lower Side Effects

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. U.S. Emerging Lung Cancer Therapeutics MarketsNovel Targeted Therapies Lower Side Effects "Standard doses of chemotherapy may prove to be life threatening in the vast majority of lung cancer patients. Novel targeted therapeutics in combination with chemotherapy are expected to make lung cancer more manageable and extend the life of patients in stages three and four of the disease." Pharmaceuticals Analyst Team Frost & Sullivan

  2. Key Features • Detailed insights into recent developments and trends • Drivers, restraints, challenges, and strategic recommendations • Analytical insights into current topics and emerging • applications in the lung cancer therapeutics market • Market-sizing and competitive analysis • Market forecasts and opportunity analyses • Quarterly assessments • End-user analysis

  3. What We Offer • Coverage: The United States • Proven methodology using extensive primary and secondary data as well as research • Focused information and strategies that cover business and technology issues • Credible data and analyses that highlight industry dynamics • Precise strategies to help you create winning business plans

  4. Who Will Benefit? Current Market Participants • Find out where you stand in comparison with the competitors • Assess current and future drivers as well as restraints • Determine and exploit new market share opportunities New Entrants • Analyze the associated challenges • Calculate timescales for strategy implementation • Position yourself to capitalize on the unmet needs of the market Investment Community • Analyze long-term strategies of companies • Determine which participants will outperform the competition • Assess the attractiveness of investing in the market

  5. Key Market Participants Abgenix Aeterna Laboratories, Inc. Allos Therapeutics Aronex Astra-Zeneca Pharmaceuticals Aventis Bristol-Myers Squibb Celgene, Inc. Cell Pathways Eli Lilly Entremed, Inc. Gaenera Corp. Glaxo-Smithkline Hoffmann La Roche IBC Pharmaceuticals, Inc. Ilex Oncology Imclone Systems, Inc. Immunex Corp. Immunogen, Inc. Inex Pharmaceuticals Isis Ivax Corp. Millennium Pharmaceuticals Novelos Therapeutics OSI Pharma Pharmacia Corp. Ribozyme Pharmaceuticals Sonus Pharmaceuticals Supergen, Inc. Titan Pharma Zarix, Inc.

  6. For More Information • Call tollfree 877 GO FROST (877.463.7876) • Fax tollfree 888.690.3329 • E-mail myfrost@frost.com • Visit www.frost.com

More Related